Total Payments
$14,111
2024 Payments
$985.56
Companies
36
Transactions
454
Medicare Patients
21,415
Medicare Billing
$1.7M
Payment Breakdown by Category
Food & Beverage$12,076 (85.6%)
Travel$1,840 (13.0%)
Education$194.21 (1.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,076 | 449 | 85.6% |
| Travel and Lodging | $1,840 | 2 | 13.0% |
| Education | $194.21 | 3 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $2,841 | 29 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $1,487 | 48 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,460 | 75 | $0 (2024) |
| Amgen Inc. | $1,185 | 39 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,095 | 31 | $0 (2024) |
| PFIZER INC. | $1,036 | 44 | $0 (2024) |
| Novo Nordisk Inc | $906.39 | 21 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $572.83 | 25 | $0 (2024) |
| Esperion Therapeutics, Inc. | $555.76 | 16 | $0 (2024) |
| GlaxoSmithKline, LLC. | $357.56 | 19 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $985.56 | 47 | Novartis Pharmaceuticals Corporation ($215.64) |
| 2023 | $1,293 | 54 | Novo Nordisk Inc ($153.34) |
| 2022 | $1,613 | 58 | Janssen Pharmaceuticals, Inc ($226.57) |
| 2021 | $1,262 | 48 | Janssen Pharmaceuticals, Inc ($268.25) |
| 2020 | $1,036 | 42 | Janssen Pharmaceuticals, Inc ($257.51) |
| 2019 | $1,803 | 64 | Amgen Inc. ($305.93) |
| 2018 | $4,440 | 75 | BOSTON SCIENTIFIC CORPORATION ($2,497) |
| 2017 | $1,679 | 66 | Novartis Pharmaceuticals Corporation ($383.58) |
All Payment Transactions
454 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $37.50 | General |
| Category: Cardiology | ||||||
| 12/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $29.03 | General |
| Category: DIABETES | ||||||
| 12/07/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $28.35 | General |
| Category: Diabetes | ||||||
| 12/03/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: Genetic Disease | ||||||
| 11/21/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/20/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $22.05 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/06/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $20.37 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/30/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $26.83 | General |
| Category: Obesity | ||||||
| 10/23/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $22.05 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/23/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/16/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: Cardiology | ||||||
| 10/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.27 | General |
| Category: DIABETES | ||||||
| 10/04/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $23.56 | General |
| Category: Cardiology | ||||||
| 09/25/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.15 | General |
| Category: Cardio-renal | ||||||
| 09/18/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $1.27 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/11/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $26.01 | General |
| Category: Respiratory | ||||||
| 09/10/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $21.08 | General |
| Category: Not Applicable | ||||||
| 08/28/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $21.97 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/20/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $22.99 | General |
| Category: Not Applicable | ||||||
| 08/14/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $21.43 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/13/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $13.61 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 08/09/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $23.51 | General |
| Category: Diabetes | ||||||
| 08/06/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $20.33 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/02/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 33 | 5,074 | 7,304 | $1.5M | $436,756 |
| 2022 | 35 | 5,197 | 7,451 | $1.4M | $422,013 |
| 2021 | 40 | 5,372 | 7,645 | $1.4M | $419,111 |
| 2020 | 43 | 5,772 | 8,141 | $1.3M | $398,285 |
Total Patients
21,415
Total Services
30,541
Medicare Billing
$1.7M
Procedure Codes
159
All Medicare Procedures & Services
159 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 690 | 1,081 | $297,275 | $100,261 | 33.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 454 | 454 | $102,150 | $59,860 | 58.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 438 | 888 | $222,000 | $59,659 | 26.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 327 | 339 | $305,100 | $51,881 | 17.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 270 | 357 | $117,810 | $48,650 | 41.3% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 167 | 241 | $48,200 | $24,451 | 50.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 739 | 1,247 | $149,640 | $13,665 | 9.1% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 210 | 213 | $31,950 | $12,704 | 39.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 56 | 56 | $22,400 | $9,412 | 42.0% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 32 | 34 | $13,600 | $7,680 | 56.5% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2023 | 190 | 291 | $21,825 | $7,528 | 34.5% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 88 | 93 | $32,550 | $5,192 | 16.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 145 | 145 | $7,250 | $4,563 | 62.9% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 144 | 144 | $21,600 | $4,142 | 19.2% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 89 | 103 | $12,875 | $4,034 | 31.3% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2023 | 149 | 149 | $7,450 | $3,028 | 40.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 30 | 207 | $10,350 | $2,248 | 21.7% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 96 | 104 | $12,480 | $2,207 | 17.7% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 13 | 13 | $2,925 | $2,186 | 74.8% |
| 76706 | Ultrasound scan of abdominal aorta | Office | 2023 | 18 | 18 | $3,600 | $2,016 | 56.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 13 | 13 | $4,290 | $1,756 | 40.9% |
| 93226 | Electrocardiogram (ecg) 2-day continuous with report | Office | 2023 | 52 | 52 | $5,200 | $1,367 | 26.3% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 65 | 65 | $3,250 | $1,239 | 38.1% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 25 | 37 | $3,700 | $1,188 | 32.1% |
| 93270 | Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring | Office | 2023 | 145 | 159 | $15,900 | $1,042 | 6.6% |
About Dr. Eric Johnson, MD
Dr. Eric Johnson, MD is a Cardiovascular Disease healthcare provider based in Plymouth, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/27/2005. The National Provider Identifier (NPI) number assigned to this provider is 1184610958.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Johnson, MD has received a total of $14,111 in payments from pharmaceutical and medical device companies, with $985.56 received in 2024. These payments were reported across 454 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($12,076).
As a Medicare-enrolled provider, Johnson has provided services to 21,415 Medicare beneficiaries, totaling 30,541 services with total Medicare billing of $1.7M. Data is available for 4 years (2020–2023), covering 159 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Plymouth, MA
- Active Since 09/27/2005
- Last Updated 06/06/2012
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1184610958
Products in Payments
- WATCHMAN (Device) $2,824
- XARELTO (Drug) $1,487
- ENTRESTO (Drug) $1,186
- Repatha (Biological) $1,094
- ELIQUIS (Drug) $747.46
- FARXIGA (Drug) $585.16
- JARDIANCE (Drug) $425.78
- BRILINTA (Drug) $348.32
- Tresiba (Drug) $336.28
- NEXLETOL (Drug) $334.46
- VYNDAQEL (Drug) $313.19
- LEQVIO (Drug) $273.53
- Victoza (Drug) $223.67
- NEXLIZET (Drug) $221.30
- ONPATTRO (Drug) $201.68
- Kerendia (Drug) $186.54
- Arcalyst (Drug) $180.44
- Xience V coronary stent system (Device) $174.88
- LifeVest (Device) $169.10
- EUCRISA (Drug) $167.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Plymouth
Dr. Glen Garson, Md, MD
Cardiovascular Disease — Payments: $8,512
Cardiovascular Disease $8,512
Robert Scarlatelli, M.d, M.D
Cardiovascular Disease — Payments: $8,045
Cardiovascular Disease $8,045
Dr. Frank Addo, Md, MD
Cardiovascular Disease — Payments: $5,779
Cardiovascular Disease $5,779
Craig Cooper
Cardiovascular Disease — Payments: $5,168
Cardiovascular Disease $5,168
Dr. Adeeb Al-Quthami, Md, MD
Cardiovascular Disease — Payments: $3,726
Cardiovascular Disease $3,726
Sushil Singh, M.d, M.D
Cardiovascular Disease — Payments: $2,285
Cardiovascular Disease $2,285